BioCentury
ARTICLE | Company News

Boulder Diagnostics Inc., Multimmune deal

January 18, 2010 8:00 AM UTC

Boulder Diagnostics will develop a blood-based heat shock protein 70 (Hsp70) lateral flow point-of-care test for Multimmune to determine which patients would benefit from hsp-70-derived treatments. T...